The Latest Breaking News from Omicron

The omicron-specific booster vaccine hit the market — some wonder if it's worth getting

Last month, the FDA authorized omicron-specific vaccines, accompanied by breathless science-by-press release and a media blitz. Just days after the FDA’s move, the Centers for Disease Control and Prevention followed, recommending updated boosters for anyone age 12 and up who had received at least two doses of the original COVID-19…

Unlike other approved vaccines, which only target the original Wuhan strain, this one also targets the original Omicron BA.1 strain.

What is different about the updated booster shots? Two scientists offer their expertise to answer five questions about the shots.

The Government's reported plan to scrap the traffic light system is premature and will leave New Zealand with few options to respond to more severe variants or other pandemic threats.

Level 2 indicates that while COVID is still spreading, the number of infections is either stable or declining

More Canberrans were back in the office in August despite concerns about the Omicron variant.

Experts are voicing concerns about the potential for vaccine providers to mix up the omicron booster vial with those used for conventional vaccines.

Fainting and fatigue may signal onset of variant, experts say